Long
[XRPH19][LONG][10X][51.6% ROE] Ripple Long Shot

Trade: LONG XRPH19
Leverage: 10x
Buy In: Up to 0.00009333
Time Frame: 4H
Targets:
(1) 0.00009596
(2) 0.00009811
(3) Hold...
Stop Loss: Close 4H candle below 0.00009150
Profit Potential: 51.6% ROE
Capital Allocation: <5%.
Notes:
Enjoy the trade.
Namaste.
Leverage: 10x
Buy In: Up to 0.00009333
Time Frame: 4H
Targets:
(1) 0.00009596
(2) 0.00009811
(3) Hold...
Stop Loss: Close 4H candle below 0.00009150
Profit Potential: 51.6% ROE
Capital Allocation: <5%.
Notes:
- For target (3) leave a portion of your holdings behind in wait for higher targets.
- Raise stop loss above buy in level after we hit our first target.
Enjoy the trade.
Namaste.
Trade active
Note
Important: Please hit LIKE to support us and keep the trades coming.Your continued support is truly appreciated.
Any questions please use the comments section below.
Note
Targets: (1) 0.00009596 -Reached 9-Jan.
(2) 0.00009811 -Next target.
(3) Hold...
Trade closed: target reached
Trade closed, our stop hits.As a rule of thumb, we raise stop loss above buy in price after we hit our first target.
🚨 You need PREMIUM trade-numbers to profit from Cryptocurrencies —Best timing & amazing results! 👉 lamatrades.com (Since 2017)
💥💥💥 Early 2025 Results (NEW)
t.me/masteranandatrades/6109
🏆 FREE Trade-Numbers
anandatrades.com
💥💥💥 Early 2025 Results (NEW)
t.me/masteranandatrades/6109
🏆 FREE Trade-Numbers
anandatrades.com
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
🚨 You need PREMIUM trade-numbers to profit from Cryptocurrencies —Best timing & amazing results! 👉 lamatrades.com (Since 2017)
💥💥💥 Early 2025 Results (NEW)
t.me/masteranandatrades/6109
🏆 FREE Trade-Numbers
anandatrades.com
💥💥💥 Early 2025 Results (NEW)
t.me/masteranandatrades/6109
🏆 FREE Trade-Numbers
anandatrades.com
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.